Philipose G. Mulugeta

Radiology | Nuclear Medicine

Nuclear Medicine & Clinical Molecular Imaging, 1 Donner, 3400 Spruce Street
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Best Practices for Treatment Team Collaboration in the Use of Radiopharmaceutical Therapy in the United States.

Best Practices for Treatment Team Collaboration in the Use of Radiopharmaceutical Therapy in the United States.

Journal: JCO oncology practice

Published: July 13, 2026

Advances in Diabetes Medications and Patient Preparation for Oncologic FDG PET: AJR Expert Panel Narrative Review.

Advances in Diabetes Medications and Patient Preparation for Oncologic FDG PET: AJR Expert Panel Narrative Review.

Journal: AJR. American journal of roentgenology

Published: July 08, 2026

Creating a dedicated radionuclide therapy clinic and leveraging telemedicine to increase access to radiopharmaceutical therapies.

Creating a dedicated radionuclide therapy clinic and leveraging telemedicine to increase access to radiopharmaceutical therapies.

Journal: Clinical imaging

Published: November 12, 2025

A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT.

A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 04, 2025

ACR-ACNM-ARS-SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride.

ACR-ACNM-ARS-SNMMI Practice Parameter for the Performance of Therapy With Radium-223 Dichloride.

Journal: American journal of clinical oncology

Published: August 25, 2025

Differential Response to 177Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.

Differential Response to 177Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 30, 2025

The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer.

The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer.

Journal: The oncologist

Published: June 02, 2025

Safety of the Combination of External Beam Radiotherapy with 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer.

Safety of the Combination of External Beam Radiotherapy with 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: April 29, 2025

Quality and Safety Considerations for Radiopharmaceutical Therapy in the Radiation Oncology Environment: An ASTRO Safety White Paper.

Quality and Safety Considerations for Radiopharmaceutical Therapy in the Radiation Oncology Environment: An ASTRO Safety White Paper.

Journal: Practical radiation oncology

Published: February 19, 2025

Management of Dry Mouth Toxicity Following 177Lu-PSMA-617 Radioligand Therapy.

Management of Dry Mouth Toxicity Following 177Lu-PSMA-617 Radioligand Therapy.

Journal: Practical radiation oncology

Published: September 03, 2024

Molecular Imaging and Therapy of Differentiated Thyroid Carcinoma in Adults.

Molecular Imaging and Therapy of Differentiated Thyroid Carcinoma in Adults.

Journal: Cancer journal (Sudbury, Mass.)

Published: May 16, 2024

Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy.

Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy.

Journal: Practical radiation oncology

Published: February 16, 2024

Showing 1-12 of 13

Last Updated: 09/26/2026